Ensign Peak Advisors
TWST icon

Ensign Peak Advisors’s Twist Bioscience TWST Stock Holding History

Ensign Peak Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.65M Sell
74,314
-698
-0.9% -$45.4K 0.01% 486
2026
Q1 		$3.56M Sell
75,012
-137,581
-65% -$6.17M 0.01% 598
2025
Q4 		$6.74M Sell
212,593
-13,679
-6% -$427K 0.01% 480
2025
Q3 		$6.37M Buy
226,272
+61,000
+37% +$1.85M 0.01% 551
2025
Q2 		$6.08M Sell
165,272
-35,555
-18% -$1.23M 0.01% 595
2025
Q1 		$7.88M Sell
200,827
-128,145
-39% -$5.77M 0.02% 525
2024
Q4 		$15.3M Sell
328,972
-1,932
-0.6% -$87.3K 0.03% 368
2024
Q3 		$15M Sell
330,904
-469
-0.1% -$22.3K 0.03% 376
2024
Q2 		$16.3M Buy
331,373
+141,557
+75% +$5.77M 0.03% 346
2024
Q1 		$6.51M Buy
189,816
+23,691
+14% +$855K 0.01% 560
2023
Q4 		$6.12M Buy
166,125
+5,097
+3% +$118K 0.01% 571
2023
Q3 		$3.26M Sell
161,028
-720
-0.4% -$15.8K 0.01% 685
2023
Q2 		$3.31M Hold
161,748
– – 0.01% 707
2023
Q1 		$2.44M Sell
161,748
-406,696
-72% -$8.98M 0.01% 763
2022
Q4 		$13.5M Buy
568,444
+449,974
+380% +$13M 0.03% 354
2022
Q3 		$4.17M Buy
118,470
+46,769
+65% +$1.99M 0.01% 564
2022
Q2 		$2.51M Hold
71,701
– – 0.01% 726
2022
Q1 		$3.54M Sell
71,701
-89,504
-56% -$4.96M 0.01% 685
2021
Q4 		$12.5M Buy
161,205
+89,435
+125% +$9.18M 0.02% 415
2021
Q3 		$7.68M Buy
71,770
+13,791
+24% +$1.58M 0.02% 501
2021
Q2 		$7.72M Buy
57,979
+7,069
+14% +$822K 0.02% 500
2021
Q1 		$6.31M Sell
50,910
-139,725
-73% -$21.2M 0.01% 545
2020
Q4 		$26.9M Buy
190,635
+33,637
+21% +$3.73M 0.06% 262
2020
Q3 		$11.9M Buy
156,998
+9,563
+6% +$595K 0.03% 406
2020
Q2 		$6.68M Buy
147,435
+20,038
+16% +$719K 0.02% 525
2020
Q1 		$3.9M Sell
127,397
-6,059
-5% -$163K 0.01% 585
2019
Q4 		$2.8M Buy
+133,456
New +$3.12M 0.01% 890

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Ensign Peak Advisors's TWST Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Twist Bioscience (TWST) stake by 0.93% in Q2 2026, selling an estimated $45.4K and leaving 74,314 shares worth $7.65M. The position accounts for 0.01% of the portfolio, ranked #486.

Ensign Peak Advisors first reported a position in TWST in Q4 2019 and has held it in 27 quarters since. The position peaked at $26.9M in Q4 2020. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Ensign Peak Advisors held 74,314 shares of Twist Bioscience worth $7.65M as of Q2 2026.
  • Ensign Peak Advisors sold 698 Twist Bioscience shares in Q2 2026, an estimated $45.4K.
  • Twist Bioscience made up 0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #486 holding.
  • Ensign Peak Advisors first reported a position in Twist Bioscience in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Twist Bioscience position peaked at $26.9M in Q4 2020.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.